logo
Breathing in America Is Going to Get More Dangerous

Breathing in America Is Going to Get More Dangerous

Yahoo09-04-2025
When you inhale a microscopic speck of soot, its journey may go like this: The particle enters your nose and heads into your lungs, penetrating even the tiny air sacs that facilitate gas exchange. Next it may slip into your bloodstream and flow into your heart, or past the blood-brain barrier. Most of us inhale some of these tiny particles every day. But inhaling enough can turn the act of breathing into an existential hazard, prompting or worsening asthma, COPD, respiratory infections, and permanent lung damage. In the heart, the specks can trigger heart disease, heart attacks, and most of the cardiovascular disorders you can think of. Air pollution is also associated with depression and anxiety, and with higher rates of suicide. It can trigger strokes and is linked to dementia or—even at average levels in this country—Parkinson's disease.
These particles can also cross the placenta, where they can reduce an infant's lung function before birth. A pre-polluted baby is also more likely to arrive prematurely, and at a lower weight. Exposure to bad air in utero is associated with a higher risk of autism, and exposure in childhood has been linked to behavioral and cognitive problems, including lower IQ. A person's lungs can develop until age 25, and as Alison Lee, a pulmonologist at the Icahn School of Medicine at Mount Sinai, put it to me, 'once you've lost lung function, you can't get it back.' Persistent exposure to air pollution can cause permanent harm, creating health problems for children and setting them up to become sicker adults.
It's hard to picture a person dropping dead from air pollution, yet it happens all the time. In the United States, particulate matter is estimated to kill more than twice as many people as vehicular accidents do—in total, some 100,000 to 200,000 people a year, as an underlying factor of chronic disease or by way of heart attacks, asthma attacks, and other sudden events. Even as air quality in America has improved, researchers have found that relatively low concentrations of particulate matter can cause major hazards.
All of this stems from a toxic and mostly invisible danger, largely the product of burning things for fuel and letting the remnant drift into the air and then into us—which is what happens unless the government regulates that process. The Trump administration, however, has shown little interest in doing so. Through new policies and aggressive cuts, the administration is taking steps that will encourage more pollution while muffling the science that shows the harms. The very air that Americans breathe will likely become less safe.
So far, the EPA has announced that it will pursue a suite of rollbacks of environmental rules, among them a Joe Biden–era update to standards for particulate matter that were meant to be fully in force by 2032 and that the Biden EPA projected would, in that year alone, prevent up to 4,500 premature deaths and 800,000 cases of asthma, reaping up to $46 billion in health benefits. It also plans to reassess a rule limiting the amount of airborne mercury and arsenic that power plants can release. In a statement announcing one of these rollbacks, the EPA said that the U.S. has already made major gains in air quality, implying that these are enough. In response to a request for comment, an agency spokesperson told me that EPA Administrator Lee Zeldin's priority is 'clean air, land, and water for EVERY American.'
The air in the U.S. certainly is cleaner than it was when industrial air pollution billowed into the skies unmitigated. Over the past 25 years alone, particulate air pollution in the country has dropped by more than 30 percent. Yet at least one in three Americans lives in a place where the air is still a health hazard. The particulate-matter standard that Zeldin intends to roll back is still nearly twice as high as the limit the World Health Organization recommends to protect health.
Rolling back rules will take time, but America's air quality could worsen in the interim. The EPA told businesses last month that they can simply email the agency if they want an exemption from certain pollution regulations and that 'the president will make a decision.' However they address those pleas, this opens a back door. The recent cuts to EPA personnel almost certainly mean that enforcement will suffer too. Meanwhile, worsening wildfire seasons, fueled by climate warming, are reversing decades of air-quality progress in this country. And ignoring and even stoking climate change, as Donald Trump's administration is doing, will produce worse wildfire seasons. The country's slide back toward its more polluted past 'will become a steeper trajectory,' Joan Casey, an environmental epidemiologist at the University of Washington whose work helped expose the connection between wildfire smoke and dementia risk, told me.
The administration's cuts to scientific research mean, too, that the impact of its deregulation may never be fully understood. In recent months, the government has pulled down some air-quality data and canceled grants; it also plans to dissolve a whole EPA division dedicated to studying how the environment affects public health. These actions create a sort of purposeful naivete: You can't regulate what you can't prove is harmful, and you can't prove harm without research.
And you certainly can't solve for what you don't yet know is a problem. The EPA's newer findings about how air pollution may addle a body—by worsening mental health or triggering more cases of neurodegenerative disease, for example—haven't yet been included in its risk-benefit assessments of air-quality regulations, Casey added. 'I think often we're underestimating the true impact,' she said.
When I called Marianthi-Anna Kioumourtzoglou, an epidemiologist at Columbia University, she had just learned that the Trump administration had canceled her grant to study how impacts of climate change, including air pollution, alter cognitive function in aging people. (Earlier this year, too, she was dismissed from her appointment to the EPA's Clean Air Scientific Advisory Committee, along with the rest of the panel.) Even so, the basics on air pollution have been studied enough that Kioumourtzoglou knows how current rollbacks will affect Americans: There will be 'more heart attacks, more respiratory adverse health outcomes for sure,' she told me. 'Our cognitive functions are going to be worse—the progression of Alzheimer's, the progression of Parkinson's.' Pollution-related depression and anxiety may go up. Even slightly increasing the risk or rate of any of these at the population level can diminish quality of life and, ultimately, productivity, she said. A sicker country is a poorer one.
Compared with smoking, for example, an individual's risk of inhaling a dangerous amount of air pollution and then having their health affected because of it is relatively small, she told me—but 'the problem is that few people smoke, and everybody breathes.' If a portion of the population's cognitive function is diminished, even a little bit, the overall impact is enormous.
Kioumourtzoglou wonders, too, how much further the Trump administration will push the idea that air pollution should not be a concern to Americans. When the Heritage Foundation published a report in December that made the radical case that no definitive link exists between air pollution and poor public-health outcomes, she disregarded it. But after watching other Heritage Foundation goals be enacted, she is concerned that its rationale could be taken seriously by the current administration. The Heritage report attempts to cast doubt on the validity of decades of science by, in part, arguing that studies linking air pollution to health effects fail to prove causation, because they're not randomized or controlled. (The Heritage Foundation did not respond to requests for comment.)
This is an attack not just on air-pollution research but on an entire scientific approach. Most public-health research is observational by necessity, because exposing people to air pollution in a lab setting to see how sick they get, say, wouldn't be ethical. Instead, scientists gather data from already-exposed populations and try to parse out how different variables affected people's health. Over decades, researchers have developed biostatistical methods to determine causal relationships from large groups of studies.
When EPA scientists and regulators link a pollutant and a health outcome, 'they're not making that assessment on one or two or three studies. It's decades of scientific publications,' Corwin Zigler, a biostatistician at Brown University who served on an EPA scientific advisory panel on air pollution under the Biden administration, told me. He wasn't surprised by the logic behind the Heritage Foundation report: The leader of the previous Trump administration's air-pollution advisory panel had begun to sow doubt about basic air-pollution research. In response, the National Academies of Sciences, Engineering, and Medicine undertook a major review of the way the EPA assesses causal relationships, and though it recommended that the EPA's process be more transparent, it found its methods scientifically robust. Zigler said he has no doubt that particulate matter is causing harm at current levels in the United States: 'That's the scientific consensus. That takes very seriously all of the limitations of any given scientific study.'
Studies about how entire populations are harmed by air pollution are framed in probabilities and percentages, but they represent a multitude of individuals for whom daily living has been made tangibly worse. For Lee, the Mount Sinai pulmonologist, work became personal a few years ago, when her son, now 5, began having asthma attacks that would send him to the emergency room. Asthma is a common-enough ailment that an attack might seem like a routine and manageable health issue. But anyone who's had a severe one will tell you differently. Over years of reporting on air pollution, I've had asthma attacks described to me as feeling like someone is stepping with their full weight on your ribcage, or as though you are suddenly a fish out of water, suffocating on land. It's a traumatic event. Lee, knowing what she does about air pollution, decided to move her family from New York City to the suburbs a year and a half ago; they haven't been to the emergency room since.
'Clearly, we know that where you live determines your health,' Lee told me, but few people can make a choice like she did, to upend their life to breathe cleaner air. The Trump administration is also cutting the programs intended to address exactly these geographic disparities, while working to make the air worse for everyone. EPA Administrator Zeldin has said these rollbacks are part of the administration's plan to 'unleash the Golden Age of American prosperity.' But prosperity does not mean choking to death in one's own home or depriving a child of cognitive capacity. Whatever wealth is promised here is narrowly disbursed at others' expense.
Article originally published at The Atlantic
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

New study raises concerns about impact of common toxin on the brain: 'Significant neurotoxicity and metabolic disruptions'
New study raises concerns about impact of common toxin on the brain: 'Significant neurotoxicity and metabolic disruptions'

Yahoo

timean hour ago

  • Yahoo

New study raises concerns about impact of common toxin on the brain: 'Significant neurotoxicity and metabolic disruptions'

New study raises concerns about impact of common toxin on the brain: 'Significant neurotoxicity and metabolic disruptions' A new study is sounding alarms about the potential damage "forever chemicals" can do to our brains, including disrupting memory, emotional regulation, and behavior. What's happening? Scientists from China exposed mice to low levels of PFAS (per- and polyfluoroalkyl substances) mixtures, similar to the levels commonly found in drinking water near contamination sites, over a seven-week period. The findings, published in the Journal of Hazardous Materials, revealed that four types of PFAS, including PFOS and PFHpA, built up in the brain and interfered with cognitive functions. The exposed mice experienced anxiety-like behavior, impaired memory, and reduced attention. Brain scans showed that key brainwaves associated with learning and focus had shifted, and researchers discovered neuron damage in the hippocampus, the region responsible for memory. Chemical analysis confirmed changes in neurotransmitter systems and inflammation in brain tissue. "This study demonstrated that long-term exposure to environmentally relevant concentrations of a PFAS mixture resulted in significant neurotoxicity and metabolic disruptions in mice," the study's authors wrote. Why are PFAS concerning? PFAS are widely used in water-resistant clothing, nonstick cookware, cosmetics, and food packaging. Because they don't break down, they can accumulate in water, soil, and the human body over time. Most Americans already have detectable levels of PFAS in their blood, and many are unknowingly exposed through tap water, dust, or everyday products. While this study was conducted on mice, the findings reflect similar human studies that have linked prenatal PFAS exposure to developmental delays in children. The ability of PFAS to breach the blood-brain barrier and alter neurotransmitters raises serious concerns about long-term effects on memory, mood, and learning. In terms of long-term health, PFAS can lead to increased risks of cancers, immune system disruptions, and negative impacts on reproductive systems. What's being done about PFAS exposure? While broader policy action is essential, individuals can take small steps to protect themselves, such as using water filters certified to remove PFAS, avoiding nonstick or stain-resistant products, and steering clear of industrial items labeled with "fluoro" or "PTFE" to help reduce exposure. On a larger scale, several states are banning PFAS in consumer goods, and advocacy groups are pushing for stronger federal protections. By supporting clean-water efforts and safer product standards, we can move toward a healthier, more sustainable future, one where dangerous chemicals no longer accumulate in our homes, our water, or our bodies. Do you worry about having toxic forever chemicals in your home? Majorly Sometimes Not really I don't know enough about them Click your choice to see results and speak your mind. Join our free newsletter for weekly updates on the latest innovations improving our lives and shaping our future, and don't miss this cool list of easy ways to help yourself while helping the planet. Solve the daily Crossword

Mizuho Keeps Buy Rating on UnitedHealth Group (UNH) Stock
Mizuho Keeps Buy Rating on UnitedHealth Group (UNH) Stock

Yahoo

time2 hours ago

  • Yahoo

Mizuho Keeps Buy Rating on UnitedHealth Group (UNH) Stock

UnitedHealth Group Incorporated (NYSE:UNH) is one of the Oversold Fundamentally Strong Stocks to Buy Now. On August 7, Mizuho analyst Ann Hynes kept her 'Buy' rating, expecting long-term value despite reducing the price objective to $300. The analyst noted that the company has reinstated its 2025 earnings guidance. The analyst believes that pricing pressure and increased medical cost trends will continue into 2026. Furthermore, the analyst also highlighted the underperformance in Optum Health's value-based care and Optum Insight segments. Despite these factors, Hynes opines that UnitedHealth Group Incorporated (NYSE:UNH)'s scale, market position, and diversified business are the key strengths, and believes that the stock's valuation is attractive. A senior healthcare professional giving advice to a patient in a clinic. UnitedHealth Group Incorporated (NYSE:UNH)'s Q2 2025 revenues increased $12.8 billion YoY to $111.6 billion. This was aided by growth in UnitedHealthcare and Optum. Notably, the Q2 2025 consolidated medical care ratio stood at 89.4%, reflecting an increase of 430 bps YoY. This was mainly because of medical cost trends, which significantly surpassed pricing trends, such as both unit costs and the intensity of services delivered, and the ongoing impacts of Medicare funding reductions. Hotchkis & Wiley, an investment management company, released its Q2 2025 investor letter and mentioned UnitedHealth Group Incorporated (NYSE:UNH). Here is what the fund said: 'UnitedHealth Group Incorporated (NYSE:UNH) is a large US health insurer. Until very recently, UNH traded at a material premium to its peers, reflecting its status as a premium growth stock with momentum. We did not own the stock. However, recent negative headlines, combined with the first earnings miss in 10 years, resulted in a >50% selloff in the company's shares. This decline contributed positively to the strategy's relative performance vs. the index, where UNH was a meaningful weight. We purchased UNH shares after the selloff at what we believe is a compelling valuation.' While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey.

Mizuho Keeps Buy Rating on UnitedHealth Group (UNH) Stock
Mizuho Keeps Buy Rating on UnitedHealth Group (UNH) Stock

Yahoo

time2 hours ago

  • Yahoo

Mizuho Keeps Buy Rating on UnitedHealth Group (UNH) Stock

UnitedHealth Group Incorporated (NYSE:UNH) is one of the Oversold Fundamentally Strong Stocks to Buy Now. On August 7, Mizuho analyst Ann Hynes kept her 'Buy' rating, expecting long-term value despite reducing the price objective to $300. The analyst noted that the company has reinstated its 2025 earnings guidance. The analyst believes that pricing pressure and increased medical cost trends will continue into 2026. Furthermore, the analyst also highlighted the underperformance in Optum Health's value-based care and Optum Insight segments. Despite these factors, Hynes opines that UnitedHealth Group Incorporated (NYSE:UNH)'s scale, market position, and diversified business are the key strengths, and believes that the stock's valuation is attractive. A senior healthcare professional giving advice to a patient in a clinic. UnitedHealth Group Incorporated (NYSE:UNH)'s Q2 2025 revenues increased $12.8 billion YoY to $111.6 billion. This was aided by growth in UnitedHealthcare and Optum. Notably, the Q2 2025 consolidated medical care ratio stood at 89.4%, reflecting an increase of 430 bps YoY. This was mainly because of medical cost trends, which significantly surpassed pricing trends, such as both unit costs and the intensity of services delivered, and the ongoing impacts of Medicare funding reductions. Hotchkis & Wiley, an investment management company, released its Q2 2025 investor letter and mentioned UnitedHealth Group Incorporated (NYSE:UNH). Here is what the fund said: 'UnitedHealth Group Incorporated (NYSE:UNH) is a large US health insurer. Until very recently, UNH traded at a material premium to its peers, reflecting its status as a premium growth stock with momentum. We did not own the stock. However, recent negative headlines, combined with the first earnings miss in 10 years, resulted in a >50% selloff in the company's shares. This decline contributed positively to the strategy's relative performance vs. the index, where UNH was a meaningful weight. We purchased UNH shares after the selloff at what we believe is a compelling valuation.' While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 13 Cheap AI Stocks to Buy According to Analysts and 11 Unstoppable Growth Stocks to Invest in Now Disclosure: None. This article is originally published at Insider Monkey.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store